Dan Raleigh

Title: The Innovations of Dan Raleigh

Introduction

Dan Raleigh is an accomplished inventor based in Stony Brook, NY (US). He has made significant contributions to the field of biochemistry, particularly through his work on protein variants. His innovative approach has led to advancements in understanding and treating amyloid-related diseases.

Latest Patents

Dan Raleigh holds a patent for "Nucleobindin I variant protein compositions and methods of use." This invention relates to Nucleobindin-1 (NUCB1) protein variants that are capable of disaggregating amyloid fibrils and inhibiting the formation of fibrils in the presence of physiological concentrations of calcium. The patent encompasses isolated NUCB1 protein variants, nucleic acids encoding these variants, cells comprising the isolated nucleic acids, pharmaceutical compositions, and kits that include the variants. Additionally, it outlines methods for making the variants and their therapeutic uses.

Career Highlights

Throughout his career, Dan has worked with prestigious institutions such as The Rockefeller University and the State University of New York. His research has focused on the implications of protein variants in medical science, particularly in relation to amyloid diseases.

Collaborations

Dan has collaborated with notable colleagues, including Santosh T Menon and Thomas P Sakmar. These partnerships have furthered his research and contributed to the scientific community's understanding of protein functions.

Conclusion

Dan Raleigh's innovative work in the field of biochemistry, particularly with Nucleobindin-1 protein variants, showcases his dedication to advancing medical science. His contributions have the potential to impact therapeutic approaches to amyloid-related diseases significantly.